Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.
Author contribution: idea, literature search and first draft, design, revision and approval of the manuscript. Tone Svilaas PhD, specialist in internal medicine and senior consultant. The author has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results